Cargando…

Disease activity and cognition in rheumatoid arthritis: an open label pilot study

INTRODUCTION: We hypothesised that fatigue in rheumatoid arthritis (RA) is related to TNF-alpha induced dysregulation of cerebral blood flow. Our objectives were to assess fatigue, cognitive function and cerebral blood flow before and after initiation of anti-TNF treatment. METHODS: In a pilot study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raftery, Graham, He, Jiabao, Pearce, Ruth, Birchall, Daniel, Newton, Julia L, Blamire, Andrew M, Isaacs, John D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674605/ https://www.ncbi.nlm.nih.gov/pubmed/23211089 http://dx.doi.org/10.1186/ar4108

Ejemplares similares

Cerebral vascular control is associated with skeletal muscle pH in chronic fatigue syndrome patients both at rest and during dynamic stimulation()
por: He, Jiabao, et al.
Publicado: (2013)

Intracranial compliance is associated with symptoms of orthostatic intolerance in chronic fatigue syndrome
por: Finkelmeyer, Andreas, et al.
Publicado: (2018)

Antioxidant intervention in rheumatoid arthritis: results of an open pilot study
por: van Vugt, Richard M., et al.
Publicado: (2008)

Supplemental treatment of rheumatoid arthritis with natural milk antibodies against enteromicrobes and their toxins: results of an open-labelled pilot study
por: Katayama, Kou, et al.
Publicado: (2011)

Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial
por: Pratt, Arthur G, et al.
Publicado: (2021)

Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study
por: Isaacs, John D, et al.
Publicado: (2019)

Measuring the impact of an educational intervention in rheumatoid arthritis: An open-label, randomized trial
por: Michou, Laëtitia, et al.
Publicado: (2021)

Grey and white matter differences in Chronic Fatigue Syndrome – A voxel-based morphometry study
por: Finkelmeyer, Andreas, et al.
Publicado: (2017)

Rituximab for Refractory Rheumatoid Arthritis: A 24-Week Open-Label Prospective Study
por: Ho, Ling Yin, et al.
Publicado: (2007)

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission
por: Chatzidionysiou, Katerina, et al.
Publicado: (2016)

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status
por: van der Bijl, Arie E., et al.
Publicado: (2008)

Efficacy of Vitamin E in Methotrexate-Induced Hepatotoxicity in Rheumatoid Arthritis: An Open-Label Case-Control Study
por: Vaidya, Binit, et al.
Publicado: (2020)

Chinese Herbal Formula Huayu-Qiangshen-Tongbi Decoction Compared With Leflunomide in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis: An Open-Label, Randomized, Controlled, Pilot Study
por: Wu, Jiaqi, et al.
Publicado: (2020)

Current concepts in the pathogenesis of early rheumatoid arthritis
por: Pratt, Arthur G., et al.
Publicado: (2009)

Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study
por: Ishibashi, Toru, et al.
Publicado: (2012)

Cognitive dysfunction in patients of rheumatoid arthritis
por: Chaurasia, Neha, et al.
Publicado: (2020)

Anakinra (Kineret) in psoriasis and psoriatic arthritis: a single-center, open-label, pilot study
por: Gibbs, A, et al.
Publicado: (2005)

An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
por: Cohen, Stanley, et al.
Publicado: (2019)

Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension
por: Burmester, Gerd R, et al.
Publicado: (2019)

Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study
por: Kubo, Satoshi, et al.
Publicado: (2023)

Inflammasomes in rheumatoid arthritis: a pilot study
por: Jiang, Qi, et al.
Publicado: (2023)

Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study
por: Mochizuki, Takeshi, et al.
Publicado: (2021)

Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial
por: Vij, Ridhima, et al.
Publicado: (2022)

Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study
por: Genovese, Mark C., et al.
Publicado: (2019)

Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial
por: Shirayama, Yukihiko, et al.
Publicado: (2014)

Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East
por: Hammoudeh, Mohammed, et al.
Publicado: (2015)

Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open‐Label, Long‐Term Extension Studies up to 9.5 Years
por: Pope, Janet E., et al.
Publicado: (2019)

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2018)

Cardiac sympathetic innervation associates with autonomic dysfunction in chronic fatigue syndrome – a pilot study
por: Petrides, George, et al.
Publicado: (2017)

Mapping a gene for rheumatoid arthritis on chromosome 18q21
por: Tapper, William, et al.
Publicado: (2007)

Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study
por: Schiff, Michael, et al.
Publicado: (2011)

Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
por: Halpern, M T, et al.
Publicado: (2008)

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study
por: Tebib, Jacques, et al.
Publicado: (2009)

AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis
por: Bird, Paul, et al.
Publicado: (2018)

Associations of rheumatoid arthritis and rheumatoid factor with mental health, sleep and cognition characteristics in the UK Biobank
por: Stanciu, Ioana, et al.
Publicado: (2022)

Effects of Probiotic Strains on Disease Activity and Enteric Permeability in Psoriatic Arthritis–A Pilot Open-Label Study
por: Haidmayer, Andreas, et al.
Publicado: (2020)

Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice
por: Bykerk, Vivian P, et al.
Publicado: (2012)

Fatigue in early rheumatoid arthritis: data from the Early Rheumatoid Arthritis Network
por: Ifesemen, Onosi Sylvia, et al.
Publicado: (2021)

Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis
por: Harry, Rachel A, et al.
Publicado: (2010)

A Pilot Study on Zinc Levels in Patients with Rheumatoid Arthritis
por: Mierzecki, Artur, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jmbalfbcvljj77t47d1vod2sd0